Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study

Abstract

Background: There is little information concerning the costs of psoriasis and patients’ quality of life (QoL) in Germany. Objective: To obtain data on the annual costs and QoL(to follow in a further publication) of patients with moderate to severe plaque psoriasis. Methods: Between October 2003 and February 2004, six office-based dermatologists and eight dermatology outpatient departments retrospectively documented cost-of-illness data from a societal cost perspective in 184 patients over a 12-month period. Patients were stratified into three subgroups according to their treatment scheme. Results: Mean total costs amounted to € 6,709 per patient and year. The mean PASI score was 18.2 and PBSA 28.9%. Annual costs were highest with € 8,831 in high-need patients. They also showed the highest PASI score (22.2). Conclusion: Moderate to severe plaque psoriasis is associated with tremendous costs, particularly in patients not adequately controlled by conventional therapies, while the outcomes of patients were unsatisfactory.

Quality of life of patients with Psoriasis in Alexandria- Egypt

“…Additionally, functional impairment, lost opportunities in professional life and elevated economic burden for treatment expenses can add to significant socioeconomic burden in the affected patients (25) . Care for patients with psoriasis requires not only treating physical manifestations, but it is also very important to identify and manage psychological conditions (26) . As the primary goal of QoL is to ensure the high level of well being of people despite their disabilities, nurses have a positive role in patient education, and planning nursing interventions aiming at minimizing the consequences of psoriasis, and improving patients' quality of life through effective management (27) .…”

Untitled

“…Ψυχιατρική 2017, 28: [15][16][17][18] μιας μελέτης συγκριτικής παρουσίασης της εκπαίδευσης στην ειδικότητα της Ψυχιατρικής ανάμεσα σε δύο διακριτές πε-ριόδους (2000 και 2014) που θα δημοσιευθεί στο επόμενο τεύχος της «Ψυχιατρικής». Αυτές οι περίοδοι αποκτούν ιδιαίτε-ρη σημασία καθώς η πρώτη μπορεί να θεωρηθεί αναδρομικά περισσότερο εύρωστη αλλά με απουσία στοχευμένων προ-τεραιοτήτων, ενώ η δεύτερη, στο μέσον της οικονομικής κρίσης διαγράφει ένα δύσκολο περιβάλλον με περιορισμένες δυνατότητες επιλογών.…”

How do regional factors influence psoriasis patient care in Germany?

“…Even recommendations for psoriasis therapy as based on treatment goals [10] and algorithms [11] have yet to become standard. A series of scientific studies were previously conducted with the aim of describing psoriasis treatment in Germany in terms of the epidemiology of disease, its economic aspects, and the need for and quality of patient care [1,[12][13][14][15][16][17]. The results showed the importance of psoriasis in Germany in terms of its relevant socio-economic, social, and medical aspects.…”